Jiaxing Lu1, Ming Chen2, Yufang Qin3. 1. College of Information Technology, Shanghai Ocean University, Hucheng Ring Road, Shanghai, China. 2. College of Information Technology, Shanghai Ocean University, Hucheng Ring Road, Shanghai, China. mchen@shou.edu.cn. 3. College of Information Technology, Shanghai Ocean University, Hucheng Ring Road, Shanghai, China. yfqin@shou.edu.cn.
Abstract
BACKGROUND: Predicting the drug response of the cancer diseases through the cellular perturbation signatures under the action of specific compounds is very important in personalized medicine. In the process of testing drug responses to the cancer, traditional experimental methods have been greatly hampered by the cost and sample size. At present, the public availability of large amounts of gene expression data makes it a challenging task to use machine learning methods to predict the drug sensitivity. RESULTS: In this study, we introduced the WRFEN-XGBoost cell viability prediction algorithm based on LINCS-L1000 cell signatures. We integrated the LINCS-L1000, CTRP and Achilles datasets and adopted a weighted fusion algorithm based on random forest and elastic net for key gene selection. Then the FEBPSO algorithm was introduced into XGBoost learning algorithm to predict the cell viability induced by the drugs. The proposed method was compared with some new methods, and it was found that our model achieved good results with 0.83 Pearson correlation. At the same time, we completed the drug sensitivity validation on the NCI60 and CCLE datasets, which further demonstrated the effectiveness of our method. CONCLUSIONS: The results showed that our method was conducive to the elucidation of disease mechanisms and the exploration of new therapies, which greatly promoted the progress of clinical medicine.
BACKGROUND: Predicting the drug response of the cancer diseases through the cellular perturbation signatures under the action of specific compounds is very important in personalized medicine. In the process of testing drug responses to the cancer, traditional experimental methods have been greatly hampered by the cost and sample size. At present, the public availability of large amounts of gene expression data makes it a challenging task to use machine learning methods to predict the drug sensitivity. RESULTS: In this study, we introduced the WRFEN-XGBoost cell viability prediction algorithm based on LINCS-L1000 cell signatures. We integrated the LINCS-L1000, CTRP and Achilles datasets and adopted a weighted fusion algorithm based on random forest and elastic net for key gene selection. Then the FEBPSO algorithm was introduced into XGBoost learning algorithm to predict the cell viability induced by the drugs. The proposed method was compared with some new methods, and it was found that our model achieved good results with 0.83 Pearson correlation. At the same time, we completed the drug sensitivity validation on the NCI60 and CCLE datasets, which further demonstrated the effectiveness of our method. CONCLUSIONS: The results showed that our method was conducive to the elucidation of disease mechanisms and the exploration of new therapies, which greatly promoted the progress of clinical medicine.
Entities:
Keywords:
Cell viability; Drug sensitivity; Perturbation signatures; WRFEN-XGBoost algorithm
Authors: Hesameddin Mostaghimi; Ali Reza Mehdizadeh; Mohammad Jahanbakhsh; Amir Reza Dehghanian; Ramin Askari Journal: J Cancer Res Ther Date: 2017 Oct-Dec Impact factor: 1.805
Authors: Aravind Subramanian; Rajiv Narayan; Steven M Corsello; David D Peck; Ted E Natoli; Xiaodong Lu; Joshua Gould; John F Davis; Andrew A Tubelli; Jacob K Asiedu; David L Lahr; Jodi E Hirschman; Zihan Liu; Melanie Donahue; Bina Julian; Mariya Khan; David Wadden; Ian C Smith; Daniel Lam; Arthur Liberzon; Courtney Toder; Mukta Bagul; Marek Orzechowski; Oana M Enache; Federica Piccioni; Sarah A Johnson; Nicholas J Lyons; Alice H Berger; Alykhan F Shamji; Angela N Brooks; Anita Vrcic; Corey Flynn; Jacqueline Rosains; David Y Takeda; Roger Hu; Desiree Davison; Justin Lamb; Kristin Ardlie; Larson Hogstrom; Peyton Greenside; Nathanael S Gray; Paul A Clemons; Serena Silver; Xiaoyun Wu; Wen-Ning Zhao; Willis Read-Button; Xiaohua Wu; Stephen J Haggarty; Lucienne V Ronco; Jesse S Boehm; Stuart L Schreiber; John G Doench; Joshua A Bittker; David E Root; Bang Wong; Todd R Golub Journal: Cell Date: 2017-11-30 Impact factor: 41.582
Authors: Bence Szalai; Vigneshwari Subramanian; Christian H Holland; Róbert Alföldi; László G Puskás; Julio Saez-Rodriguez Journal: Nucleic Acids Res Date: 2019-11-04 Impact factor: 16.971
Authors: Michael P Menden; Francesco Iorio; Mathew Garnett; Ultan McDermott; Cyril H Benes; Pedro J Ballester; Julio Saez-Rodriguez Journal: PLoS One Date: 2013-04-30 Impact factor: 3.240